Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis
Data from Dual-Acting Oral Biologic Show Promising Safety and Efficacy Profile […]
Category: BioUtah News
CancerVax Passes First Test with Flying Colors
Recent in-vitro lab results confirm that the Company’s Smart mRNA can be used as a potential on/off switch for selectively detecting cancer cells […]
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Unique cell-impermeable1 design extends life-saving treatment for dialysis patients. […]
Here’s how Utah earned its No. 1 ranking for innovation
A new report from the U.’s Kem C. Gardner Policy Institute uncovers the wide-ranging mechanisms driving Utah’s high performance when it comes to innovation output […]
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinics. The program, launching this month, will run for a minimum of three years. […]
Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
Study Demonstrates RiskScore as a More Accurate Predictor of Breast Cancer Risk, Doubling Accuracy Compared to the Tyrer-Cuzick Model […]
Human Forms and Body Parts Trigger Strong Reactions in the Brain
Human Forms and Body Parts Trigger Strong Reactions in the Brain […]
Canary Speech and Prism Care Announce Partnership to Enhance Extended Care Through Vocal Biomarker Technology
Partnership aims to set new industry standards for managing mental health and cognitive conditions […]
SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL APPLICATIONS
SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL APPLICATIONS […]
BD Resolves Previously Disclosed SEC Investigation
BD has reached an agreement with the U.S. SEC to resolve the previously disclosed investigation related to prior public disclosures. […]
NUSANO NAMES MEDICAL RADIOISOTOPES ADVISORY BOARD
VALENCIA, Calif. – Dec. 3, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the creation of a Medical Radioisotopes Advisory Board. This panel of internationally recognized leaders in nuclear medicine will provide strategic guidance to Nusano, ensuring its product development aligns with emerging trends and with the needs of cancer […]
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
SALT LAKE CITY, Dec. 10, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the inauguration of CoSara Diagnostics Pvt. Ltd.’s oligonucleotide synthesis facility will take place December 11, 2024, in Ranoli, India. In support of the “Make […]